Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00258570 · ClinicalTrials.gov registry record
Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
A clinical trial of Pulmonary Fibrosis, sponsored by University of Pittsburgh.
- Recruiting
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT00258570: Recruiting study of Pulmonary Fibrosis, sponsored by University of Pittsburgh.
NCT00258570 is a study of Pulmonary Fibrosis that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 2,000 participants, above the 798-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (151% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00258570, a study of Pulmonary Fibrosis, is actively recruiting participants, sponsored by University of Pittsburgh.
- RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
Primary Outcome
Blood samples will be collected to validate in a large cohort the per- allele associations of prespecified SNPs with IPF case status adjusted for age , sex. smoking, and principal components of ancestry.
Conditions Studied
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2003-01 |
| Est. Completion | 2035-07 |
What NCT00258570 shows while recruiting
NCT00258570 is an observational study that tracks outcomes without assigning an intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 798-participant average among 22 other Pulmonary Fibrosis trials with a reported enrollment target (151% higher).
The record links to 1 condition, with Pulmonary Fibrosis appearing as the primary indexed condition, and to 0 interventions.
NCT00258570 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00258570 about?
NCT00258570 is a clinical study titled "Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)". The purposes of this study are: * to determine if there are specific genetic traits that might explain why patients have developed pulmonary fibrosis; * to determine if specific genetic traits account for differing patterns of inflammation and scar tissue that has formed in the patient's lungs.
What is the current status of trial NCT00258570?
This trial is currently recruiting. The enrollment target is 2,000 participants. The study started on 2003-01. Estimated completion is 2035-07.
What conditions does trial NCT00258570 study?
This clinical trial studies the following conditions: Pulmonary Fibrosis.
Who is sponsoring clinical trial NCT00258570?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00258570 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Fibrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00258570's enrollment target sits among peer trials
2,000 3rd of 22 higher than 20 of 22 other Pulmonary Fibrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pulmonary Fibrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Advanced Imaging for Pulmonary Fibrosis
RECRUITING · Phase 2
-
Pulmonary Fibrosis Foundation Community Registry
RECRUITING
-
Interstitial Lung Disease Research Unit Biobank
RECRUITING
-
FAPI PET for Lung Fibrosis
RECRUITING · Early Phase 1
-
Single Time Point Prediction as Earlier Diagnosis of Progressive Pulmonary Fibrosis
RECRUITING
-
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001465 · 2,000 participants
Study of the Disease Process of Lymphangioleiomyomatosis
- NCT00001595 · 2,000 participants
An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
- NCT00138931 · 2,000 participants
Genetics of Cardiovascular and Neuromuscular Disease
- NCT00288119 · 2,000 participants
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia